Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Feb 2023
Historique:
received: 14 01 2023
revised: 08 02 2023
accepted: 10 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Hepatocellular carcinoma is today the sixth leading cause of cancer-related death worldwide, despite the decreased incidence of chronic hepatitis infections. This is due to the increased diffusion of metabolic diseases such as the metabolic syndrome, diabetes, obesity, and nonalcoholic steatohepatitis (NASH). The current protein kinase inhibitor therapies in HCC are very aggressive and not curative. From this perspective, a shift in strategy toward metabolic therapies may represent a promising option. Here, we review current knowledge on metabolic dysregulation in HCC and therapeutic approaches targeting metabolic pathways. We also propose a multi-target metabolic approach as a possible new option in HCC pharmacology.

Identifiants

pubmed: 36835122
pii: ijms24043710
doi: 10.3390/ijms24043710
pmc: PMC9964410
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Biomed Res Int. 2016;2016:7196280
pubmed: 27314036
Thromb Res. 2021 Feb;198:139-150
pubmed: 33340925
Cancer Metastasis Rev. 2007 Jun;26(2):225-39
pubmed: 17440684
Gastroenterology. 2019 Dec;157(6):1615-1629.e17
pubmed: 31446059
Physiol Chem Phys. 1980;12(2):99-110
pubmed: 6254102
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Pharm Regul Aff. 2014 Jul;3(2):
pubmed: 27478687
Future Oncol. 2010 Apr;6(4):551-62
pubmed: 20373869
Biochim Biophys Acta. 2000 Jun 26;1486(1):1-17
pubmed: 10856709
Med Oncol. 2012 Jun;29(2):909-14
pubmed: 21279699
Cells. 2019 Nov 08;8(11):
pubmed: 31717433
Mol Cancer Res. 2014 Jan;12(1):91-100
pubmed: 24255171
Biochim Biophys Acta. 2013 Dec;1832(12):2019-26
pubmed: 23851051
Trends Biochem Sci. 2014 Aug;39(8):347-54
pubmed: 25037503
Hepatol Res. 2017 Sep;47(10):1053-1060
pubmed: 27862729
Curr Biol. 2017 Nov 6;27(21):R1147-R1151
pubmed: 29112863
Oncotarget. 2017 Aug 14;8(40):68381-68392
pubmed: 28978124
Sci Rep. 2018 Oct 24;8(1):15707
pubmed: 30356107
Sci Rep. 2021 Jan 13;11(1):1259
pubmed: 33441568
Antioxid Redox Signal. 2007 Aug;9(8):1221-35
pubmed: 17536958
Nat Commun. 2018 Jan 31;9(1):446
pubmed: 29386513
Liver Int. 2017 Jan;37(1):80-89
pubmed: 27264722
J Proteome Res. 2018 May 4;17(5):1943-1952
pubmed: 29676152
Cancer Res. 2003 Nov 1;63(21):7330-7
pubmed: 14612531
J Hepatol. 2017 Nov;67(5):979-990
pubmed: 28647567
Hepatology. 2017 Aug;66(2):631-645
pubmed: 28387968
Oncol Lett. 2017 Feb;13(2):800-804
pubmed: 28356961
Cancer Discov. 2020 Dec;10(12):1797-1807
pubmed: 33139243
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Br J Cancer. 2017 Nov 7;117(10):1518-1528
pubmed: 28926527
J Exp Clin Cancer Res. 2017 Mar 20;36(1):44
pubmed: 28320429
Cell Death Dis. 2018 Sep 20;9(10):970
pubmed: 30237463
Oncotarget. 2018 Jan 6;9(11):9925-9939
pubmed: 29515780
Curr Top Med Chem. 2020;20(12):1093-1104
pubmed: 32091334
Cancer Res. 2013 Aug 15;73(16):4992-5002
pubmed: 23824744
Am J Physiol Gastrointest Liver Physiol. 2019 May 1;316(5):G598-G607
pubmed: 30817182
Trends Cancer. 2017 Mar;3(3):169-180
pubmed: 28393116
Clin Cancer Res. 2018 Jun 1;24(11):2482-2490
pubmed: 29420223
Science. 2012 May 25;336(6084):1040-4
pubmed: 22628656
Br J Nutr. 2012 Feb;107(4):473-84
pubmed: 21849094
Science. 1963 Jun 28;140(3574):1391-2
pubmed: 13979937
Biochim Biophys Acta. 2012 Jan;1820(1):1-8
pubmed: 22037246
Cell Metab. 2016 Jan 12;23(1):206-19
pubmed: 26724859
Lancet. 2018 Mar 31;391(10127):1301-1314
pubmed: 29307467
J Mol Med (Berl). 2019 Jun;97(6):741-759
pubmed: 30953079
Carcinogenesis. 2020 Jul 14;41(7):972-983
pubmed: 31628462
Nature. 2014 Sep 25;513(7519):559-63
pubmed: 25043024
Redox Biol. 2020 Sep;36:101510
pubmed: 32593127
Cancer Res. 2008 Jul 1;68(13):5246-56
pubmed: 18593925
Biochimie. 2022 Nov;202:180-189
pubmed: 35952946
Nat Commun. 2013;4:2508
pubmed: 24149070
Cell Death Dis. 2015 Nov 19;6:e1980
pubmed: 26583321
Elife. 2020 Oct 05;9:
pubmed: 33016874
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Biochem J. 2009 Feb 1;417(3):717-26
pubmed: 18945211
Cell. 2017 Jun 15;169(7):1327-1341.e23
pubmed: 28622513
Cell Death Dis. 2020 May 7;11(5):339
pubmed: 32382022
Biochimie. 2023 Jan 11;:
pubmed: 36638953
Cell Rep. 2018 Apr 3;23(1):255-269.e4
pubmed: 29617665
Biology (Basel). 2015 Feb 05;4(1):104-32
pubmed: 25665169
Biomed Pharmacother. 2022 Sep;153:113485
pubmed: 36076503
Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):607-617
pubmed: 29197664
Anticancer Res. 2009 Dec;29(12):4909-18
pubmed: 20044597
Sci Rep. 2015 Dec 10;5:18175
pubmed: 26658617
EBioMedicine. 2020 Apr;54:102699
pubmed: 32330875
Oncotarget. 2016 Apr 19;7(16):21753-62
pubmed: 26943041
Biochemistry. 2007 Apr 10;46(14):4408-16
pubmed: 17367163
Cancer Res. 2015 Feb 1;75(3):532-43
pubmed: 25589345
J Biol Chem. 2017 Dec 8;292(49):20208-20217
pubmed: 28978646
Nat Rev Mol Cell Biol. 2022 Oct 31;:
pubmed: 36316383
Plant Foods Hum Nutr. 2022 Sep;77(3):481-483
pubmed: 35831770
J Biol Chem. 2001 Oct 5;276(40):37223-9
pubmed: 11486000
Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):E725-34
pubmed: 26811478
J Cancer. 2019 Jan 29;10(4):918-926
pubmed: 30854098
Nature. 2012 Nov 15;491(7424):458-462
pubmed: 23064226
Oncogenesis. 2017 Apr 10;6(4):e312
pubmed: 28394358
Am J Pathol. 2011 Feb;178(2):652-61
pubmed: 21281797
PLoS One. 2013 Jun 05;8(6):e66294
pubmed: 23755305
Nat Med. 2018 Feb;24(2):194-202
pubmed: 29334372
J Mol Med (Berl). 2020 Feb;98(2):179-191
pubmed: 31863151
Plant Foods Hum Nutr. 2008 Jun;63(2):77-82
pubmed: 18392727
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Nat Genet. 2011 Jul 31;43(9):869-74
pubmed: 21804546
Eur J Clin Invest. 2008 Apr;38(4):245-52
pubmed: 18339004
Mol Oncol. 2022 Jun;16(11):2274-2294
pubmed: 35298869
Clin Cancer Res. 2018 Jan 15;24(2):474-485
pubmed: 29084919
J Hepatol. 2006 Jan;44(1):142-50
pubmed: 16298452
Biochem Pharmacol. 2020 Jun;176:113902
pubmed: 32156660
J Hepatol. 2022 Dec;77(6):1598-1606
pubmed: 36208844
Onco Targets Ther. 2019 Dec 31;12:11751-11763
pubmed: 32021249
RSC Adv. 2018 Oct 23;8(63):36034-36042
pubmed: 35558476
Biochem Pharmacol. 2020 Jul;177:113988
pubmed: 32330495
J Cancer Res Clin Oncol. 2015 Jul;141(7):1151-62
pubmed: 25446815
Immunol Res. 2012 Sep;53(1-3):11-24
pubmed: 22418728
Metabolism. 2011 Mar;60(3):404-13
pubmed: 20423748
Hepatology. 2011 Sep 2;54(3):920-30
pubmed: 21674557
Liver Int. 2006 May;26(4):414-23
pubmed: 16629644
Ann Hepatol. 2018 Apr 9;17(3):490-500
pubmed: 29735800
Oncogene. 2006 Aug 7;25(34):4675-82
pubmed: 16892081
Biochem Biophys Res Commun. 2016 Jun 10;474(4):673-679
pubmed: 27155152
Int J Oncol. 2014 Aug;45(2):485-92
pubmed: 24827738
Cell Metab. 2012 Feb 8;15(2):157-70
pubmed: 22326218
J Hepatol. 2014 Oct;61(4):859-66
pubmed: 24801417
Cell Rep. 2015 Dec 1;13(9):2014-26
pubmed: 26655911
Cancer Lett. 2014 Dec 1;355(1):96-105
pubmed: 25218350
Sci Rep. 2017 Oct 2;7(1):12486
pubmed: 28970582
Eur J Cancer. 2022 Jan;161:108-118
pubmed: 34942552
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
J Cell Mol Med. 2021 Feb;25(3):1468-1479
pubmed: 33393219
Hepatology. 1990 Jan;11(1):118-22
pubmed: 2153092
Biochem Biophys Res Commun. 2020 Jun 11;526(4):1150-1156
pubmed: 32321639
Cancers (Basel). 2018 Oct 30;10(11):
pubmed: 30380773
Cancers (Basel). 2018 Sep 18;10(9):
pubmed: 30231564
Adv Enzyme Regul. 1968;6:453-64
pubmed: 4305564
J Med Chem. 2012 Dec 13;55(23):10551-63
pubmed: 23151085
J Med Chem. 2019 Jan 24;62(2):589-603
pubmed: 30543285
Oncotarget. 2017 Jul 11;8(28):45965-45980
pubmed: 28498814
Gastroenterology. 2013 Feb;144(2):323-332
pubmed: 23063971
J Hepatocell Carcinoma. 2020 Feb 18;7:19-31
pubmed: 32110554
Sci Rep. 2018 Feb 15;8(1):3081
pubmed: 29449614
Biology (Basel). 2017 Feb 04;6(1):
pubmed: 28165421
Plant Foods Hum Nutr. 2023 Mar;78(1):230-232
pubmed: 36525173
Oncotarget. 2016 Jul 26;7(30):47332-47342
pubmed: 27322079
J Physiol. 2021 Mar;599(6):1745-1757
pubmed: 33347611
Plant Foods Hum Nutr. 2011 Nov;66(4):328-34
pubmed: 21964875
J Pharm Pharmacol. 2021 Sep 7;73(10):1369-1376
pubmed: 34014301
Open Biol. 2019 Jul 26;9(7):190099
pubmed: 31288625
Cancer Cell. 2006 Aug;10(2):99-111
pubmed: 16904609
Int J Biol Markers. 2017 Oct 31;32(4):e391-e396
pubmed: 28862714
Amino Acids. 2021 Aug;53(8):1169-1179
pubmed: 34292410
Front Oncol. 2021 Sep 03;11:698023
pubmed: 34540667
Oncotarget. 2012 Sep;3(9):940-53
pubmed: 22964488
Biomed Res Int. 2017;2017:5202684
pubmed: 29379799
Mol Cell. 2021 Sep 16;81(18):3749-3759
pubmed: 34469752
Sci Rep. 2017 Mar 06;7:43864
pubmed: 28262837
IUBMB Life. 2008 May;60(5):323-32
pubmed: 18421779
Nat Rev Drug Discov. 2022 Apr;21(4):283-305
pubmed: 35031766
ChemMedChem. 2021 Jul 6;16(13):2121-2129
pubmed: 33831272
JPEN J Parenter Enteral Nutr. 1999 Sep-Oct;23(5 Suppl):S33-7
pubmed: 10483891
Nature. 2011 Aug 18;476(7360):346-50
pubmed: 21760589
Pharm Biol. 2016 Jul;54(7):1223-36
pubmed: 26154521
Gastroenterology. 2014 Dec;147(6):1393-404
pubmed: 25181692
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cell Mol Gastroenterol Hepatol. 2017 May 31;4(2):303-323.e1
pubmed: 28840186
Nat Immunol. 2010 Oct;11(10):889-96
pubmed: 20856220
Oncotarget. 2017 Sep 8;8(44):77734-77751
pubmed: 29100421
J Bioenerg. 1973;4(6):533-62
pubmed: 4771418
Expert Opin Ther Targets. 2009 Dec;13(12):1411-27
pubmed: 19874261
Oncoimmunology. 2017 Jun 30;6(10):e1344804
pubmed: 29123954
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):97-102
pubmed: 29366974
J Immunol. 2013 Aug 1;191(3):1486-95
pubmed: 23817426
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Int J Cancer. 2016 Jan 15;138(2):348-60
pubmed: 26238458
BMC Cancer. 2014 Feb 20;14:110
pubmed: 24552144
Cell Metab. 2017 Oct 3;26(4):648-659.e8
pubmed: 28918937
Blood. 2018 Sep 13;132(11):1180-1192
pubmed: 30018077
Mol Cell. 2021 Feb 18;81(4):691-707.e6
pubmed: 33382985
Onco Targets Ther. 2019 Jul 08;12:5359-5373
pubmed: 31371980
J Immunol. 2008 Feb 15;180(4):2011-7
pubmed: 18250403
PLoS One. 2011;6(9):e24084
pubmed: 21909411
Sci Rep. 2015 Oct 01;5:14752
pubmed: 26424075
Br J Radiol. 2014 Mar;87(1035):20130676
pubmed: 24588669
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
PLoS One. 2014 Dec 26;9(12):e115036
pubmed: 25541689

Auteurs

Davide Gnocchi (D)

Interdisciplinary Department of Medicine, School of Medicine, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.

Carlo Sabbà (C)

Interdisciplinary Department of Medicine, School of Medicine, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.

Mara Massimi (M)

Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Antonio Mazzocca (A)

Interdisciplinary Department of Medicine, School of Medicine, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH